{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifb4qajhvlw76e6z4e6jqpaldqgt66h7r2u2ofnswrt6mnrjns67q",
    "uri": "at://did:plc:k7h5fn3kdhjpj37pc6yhno2o/app.bsky.feed.post/3mgbrre44plr2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigad23n3xbo6plqdz7ztmbzyvarhhiww6ckkkgswxolp2sxgyzyjm"
    },
    "mimeType": "image/jpeg",
    "size": 97691
  },
  "path": "/article/glp-1-diabetes-medications-lower-risk-of-all-kinds-of-substance-use/",
  "publishedAt": "2026-03-04T23:30:00.000Z",
  "site": "https://www.scientificamerican.com",
  "textContent": "A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths",
  "title": "GLP-1 diabetes medications lower risk of all kinds of substance use disorders, study finds"
}